Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Terpin hydrate is an expectorant used to treat bronchitis, pneumonia, bronchiectasis, COPD, and infectious or inflammatory diseases of the upper respiratory tract. Terpin hydrate is an expectorant, commonly used to loosen mucus and ease congestion in patients presenting with acute or chronic bronchitis, and related pulmonary conditions.
- Mechanism
- Curator reviewed · 1 reference
Terpin hydrate improves mucociliary function by working directly on the bronchial secretory cells in the lower respiratory tract to liquify and facilitate the elimination of bronchial secretionsas well as exerting a weak antiseptic effect on the pulmonary parenchyma. It is thought to increase the amount of fluid in the respiratory tract, which increases the flow and clearance of local irritants and as well as reducing the viscosity of mucus.
- Primary indication
- Terpin hydrate is used in the treatment of acute and chronic bronchitis, pneumonia, bronchiectasis, chronic obstructive pulmonary disease, infectious and inflammatory diseases of the upper respiratory tract.Curator reviewed · 6 structured indications
- Formula / weight
- C10H22O3 · 190.283 g/mol (avg)
- First approval
- Canada, 1965
- Also known as
- cis-terpin hydrate · Terpin cis-form hydrate · Terpin monohydrate · Terpinene hydrate · Terpinol hydrate
- Code names
- AI3-01762
Resolves to
JGKJMBOJWVAMIJ-OFAZAQPOSA-NSMILESO.CC(C)(O)[C@H]1CC[C@@](C)(O)CC1What you can answer from here — as of March 06, 2025
Which other approved drugs treat the same conditions as Terpin hydrate, and which companies have late-stage candidates in those indications?